Published June 27, 1997 | Version Accepted Version
Journal Article Open

Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis

Abstract

The Fas cell surface receptor induces apoptosis upon receptor oligomerization. We have identified a novel signaling protein, termed Daxx, that binds specifically to the Fas death domain. Overexpression of Daxx enhances Fas-mediated apoptosis and activates the Jun N-terminal kinase (JNK) pathway. A C-terminal portion of Daxx interacts with the Fas death domain, while a different region activates both JNK and apoptosis. The Fas-binding domain of Daxx is a dominant-negative inhibitor of both Fas-induced apoptosis and JNK activation, while the FADD death domain partially inhibits death but not JNK activation. The Daxx apoptotic pathway is sensitive to both Bcl-2 and dominant-negative JNK pathway components and acts cooperatively with the FADD pathway. Thus, Daxx and FADD define two distinct apoptotic pathways downstream of Fas.

Additional Information

© 1997 Cell Press. Under an Elsevier user license. Received 8 January 1997, Revised 8 May 1997. Correspondence regarding this paper should be addressed to D. B. We are indebted to Dr. Genhong Cheng for his help in the initial phase of this project. We thank Drs. R. Brent, Y. W. Choi, C. J. Der, D. V. Goeddel, A. Hoffmann, M. Karin, R. N. Kolesnick, P. H. Krammer, R. J. Lutz, S. Nagata, R. Treisman, D. Wallach, and J. Yuan their generous gifts of reagents, and S. W. Fesik for examining the Daxx sequence. We thank P. Svec and Y. Li for excellent technical assistance, and Drs. A. J. Koleske, B. Chen, Z. Songyang, Y. Yamanashi, I. Stancovsky and other members of Baltimore lab for valuable advice. X. Y. and R. K.-F. are fellows of the Leukemia Society of America and Irvington Research Institute, respectively. H. Y. C. is supported by the Medical Scientist Training Program at Harvard Medical School. D. B. is an American Cancer Society Research Professor. This work was supported by the NIH grant CA51462.

Attached Files

Accepted Version - nihms-242914.pdf

Files

nihms-242914.pdf

Files (445.7 kB)

Name Size Download all
md5:bd029a01f6d8999c7b096a9b3144744b
445.7 kB Preview Download

Additional details

Identifiers

PMCID
PMC2989411
Eprint ID
102729
DOI
10.1016/s0092-8674(00)80294-9
Resolver ID
CaltechAUTHORS:20200422-150958917

Related works

Funding

Leukemia Society of America
Irvington Institute for Medical Research
Harvard Medical School
American Cancer Society
NIH
CA51462

Dates

Created
2020-04-23
Created from EPrint's datestamp field
Updated
2021-11-16
Created from EPrint's last_modified field